← Back to People
Mike Doustdar, CEO of Novo Nordisk, announced a collaboration with Anthropic to accelerate drug discovery using AI-driven tools.
2
Mentions
2
Articles
2
Outlets
Companies Covered
Appears In
Articles
Most recent firstMentioned In
Referenced in coverage
Novo Nordisk partnered with Anthropic on drug discovery and AI-driven software engineering
Novo NordiskpositiveSep 19, 2026
“Mike Doustdar, CEO of Novo Nordisk, announced a collaboration with Anthropic to accelerate drug discovery using AI-driven tools.”
Novo Nordisk partnering with Anthropic
BloombergpositiveSep 17, 2026
“Announced partnership with Anthropic to use Claude Science for drug research and development acceleration.”